Asarfi Hospital Ltd
Incorporated in 2005, Asarfi Hospital Ltd
provides primary health services & treatment
and specialized super speciality health service[1]
- Market Cap ₹ 171 Cr.
- Current Price ₹ 87.1
- High / Low ₹ 112 / 52.8
- Stock P/E 41.2
- Book Value ₹ 39.3
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2024 | |
---|---|
80.93 | |
64.65 | |
Operating Profit | 16.28 |
OPM % | 20.12% |
1.67 | |
Interest | 2.92 |
Depreciation | 8.79 |
Profit before tax | 6.24 |
Tax % | 33.33% |
4.16 | |
EPS in Rs | 2.11 |
Dividend Payout % | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 14% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2024 | Sep 2024 | |
---|---|---|
Equity Capital | 19.68 | 19.68 |
Reserves | 50.73 | 54.84 |
31.91 | 43.92 | |
51.76 | 39.70 | |
Total Liabilities | 154.08 | 158.14 |
93.77 | 89.33 | |
CWIP | 0.00 | 0.58 |
Investments | 0.00 | 0.10 |
60.31 | 68.13 | |
Total Assets | 154.08 | 158.14 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2024 | |
---|---|
26.07 | |
-63.09 | |
36.41 | |
Net Cash Flow | -0.61 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2024 | |
---|---|
Debtor Days | 109.41 |
Inventory Days | 32.33 |
Days Payable | 446.55 |
Cash Conversion Cycle | -304.80 |
Working Capital Days | -3.34 |
ROCE % |
Documents
Announcements
-
Closure of Trading Window
29 Mar - Closure of trading window for insider trading.
-
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (LODR) Regulations, 2015
28 Mar - Approval of CSR policy for cervical cancer screening.
-
Intimation Of Material Event-High Court Jharkhand Order Civil Litigation Related To Cancer Hospital Land.
13 Mar - High Court removes Asarfi Hospital from civil litigation.
-
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
3 Mar - Resignation of Company Secretary effective March 3, 2025.
-
Outcome Of Board Meeting Held On 31St January, 2025 And Submission Of Unaudited Financial Results For The Quarter Ended 31St December, 2024 As Per SEBI (LODR) Regulations, 2015.
31 Jan - Board approved unaudited financial results for Q3 2024.
Annual reports
Concalls
-
Jan 2025TranscriptNotesPPT
-
Nov 2024Transcript PPT
Business Overview Asarfi Hospital Limited (AHL) operates three primary facilities:
Pharmacy Contribution: The hospital’s pharmacy contributed 25% of the revenue
Asarfi Cancer Institute (Ranguni, Dhanbad)[2]
Future Expansion: The facility is approved for construction of up to seven floors, enabling substantial expansion.
Research Institute (Ranchi)[3]